Shigeru Ushiyama

904 citations
33 papers · 757 indexed · h-index 11
Topics
Inflammatory mediators and NSAID effects (9 papers)Cancer-related Molecular Pathways (6 papers)Advanced Breast Cancer Therapies (5 papers)

In The Last Decade

Shigeru Ushiyama

33 papers receiving 740 citations

Peers

Shigeru Ushiyama
Comparison fields: 5 of 80
  • Immunology and Allergy 380
  • Molecular Biology 328
  • Immunology 185
  • Cancer Research 140
  • Oncology 110
Replace Wen‐Cherng Lee with:
Wen‐Cherng Lee United States
Françoise Perron‐Sierra France
Hollis R. Williams United States
Shama Kajiji United States
Irma M. Grossi United States
Carol Torcellini United States
Kathleen M. Gillooly United States
A Desplaces France
Kylie A. Hotchkiss United States
John T. Miller United States
Shigeru Ushiyama relative to Wen‐Cherng Lee United States Wen‐Cherng Lee's profile →
Citations per field
00.5×1.5×2.3×
Wen‐Cherng Lee · 1×
Citations per year

Countries citing papers authored by Shigeru Ushiyama

Since Specialization
Citations

This map shows the geographic impact of Shigeru Ushiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shigeru Ushiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shigeru Ushiyama more than expected).

Fields of papers citing papers by Shigeru Ushiyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shigeru Ushiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shigeru Ushiyama. The network helps show where Shigeru Ushiyama may publish in the future.

Co-authorship network of co-authors of Shigeru Ushiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Shigeru Ushiyama. A scholar is included among the top collaborators of Shigeru Ushiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shigeru Ushiyama. Shigeru Ushiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 2
4 3
5 4
6 1
7 3
8 19
9 34
10 15
11 13
12 34
13 2
14 255
15
In vitro antiplatelet profiles of the new thromboxane synthetase inhibitor sodium 2-(1-imidazolylmethyl)-4,5-dihydrobenzo[b]thiophene-6-carboxylate.
5
16 1
17 4
18 15
19 22
20
[DRUGS FOR THE TREATMENT OF ANGINA PECTORIS].
4

About Shigeru Ushiyama

Shigeru Ushiyama is a scholar working on Immunology and Allergy, Pharmacology and Oncology, having authored 33 papers that have together received 757 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Cancer-related Molecular Pathways (6 papers) and Advanced Breast Cancer Therapies (5 papers). The work is most often cited by research in Immunology and Allergy (380 citations), Cancer Research (140 citations) and Immunology (185 citations). Shigeru Ushiyama has collaborated with scholars based in Japan, Germany and United States. Frequent co-authors include Kevin L. Moore, Rodger P. McEver, Thomas M. Laue, Harold Erickson, Nancy L. Stults, Sandra Diaz, Richard D. Cummings, Ajit Varki, Keiichi Matsuda and Mitsuo Yamazaki. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026